Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 1, 2007, Pages 73-83

  Cantor, Warren J ^a,n   Mahaffey, Kenneth W ^b   Huang, Zhen ^b   Das, Pranab ^c   Gulba, Dietrich C ^d   Glezer, Stanislav ^e   Gallo, Richard ^f   Ducas, John ^g   Cohen, Marc ^h   Antman, Elliott M ⁱ   Langer, Anatoly ^a   Kleiman, Neal S ^j   White, Harvey D ^k   Chisholm, Robert J ^a   Harrington, Robert A ^b   Ferguson, James J ^l   Califf, Robert M ^b   Goodman, Shaun G ^a,m  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Krankenhaus Duren gem GmbH   (Germany)

^e SANOFI   (France)

^f MONTREAL HEART INSTITUTE   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k GREEN LANE HOSPITAL   (New Zealand)

^l TEXAS HEART INSTITUTE   (United States)

^m CANADIAN HEART RESEARCH CENTRE   (Canada)

ⁿ SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

more..

Author keywords

Blood loss; Coronary disease; Device removal; Radial artery; Surgical

Indexed keywords

ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRACHIAL ARTERY; CORONARY ARTERY BYPASS GRAFT; DEVICE; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RADIAL ARTERY; SHEATH REMOVAL; SURGICAL RISK; VASCULAR ACCESS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DEVICE REMOVAL; ENOXAPARIN; EQUIPMENT DESIGN; FEMALE; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 33845978383     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20897     Document Type: Article

References (46)

1. Cannon CP Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E: TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/ IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
2. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The access study. J Am Coll Cardiol 1997;29:1269-1275.
3. Mann T, Cubeddu G, Bowen J, Schneider JE, Arrowood M, Newman WN, Zellinger MJ, Rose GC. Stenting in acute coronary syndromes: A comparison of radial versus femoral access sites. J Am Coll Cardiol 1998;32:572-576.
4. Ricci MA, Trevisani GT, Pilcher DB. Vascular complications of cardiac catheterization. Am J Surg 1994;167:375-378.
5. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
6. Oweida SW, Roubin GS, Smith RB III, Salani AA. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg 1990;:12:310-315.
7. Messina LM, Brothers TE, Wakefield TW, Zelenock GB, Lindenauer SM, Greenfield LJ, Jacobs LA, Fellows EP, Grube SV, Stanley JC. Clinical characteristics and surgical management of vascular complications in patients undergoing cardiac catheterization: Interventional versus diagnostic procedures. J Vasc Surg 1991;13: 593-600.
8. Blankenship JC, Hellkamp AS, Aguirre FV, Demko SL, Topol EJ, Califf RM. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol 1998;81:36-40.
9. Mandak JS, Blankenship JC, Gardner LH, Berkowitz SD, Aguirre FV, Sigmon KN, Timmis GC, Gilchrist IC, McIvor M, Resar J, Weiner BH, George BS, Talley JD, Lincoff AM, Tcheng JE, Califf RM, Topol EJ and for the IMPACT II Investigators. Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to minimize platelet aggregation and coronary thrombosis. J Am Coll Cardiol 1998;31:1518-1324.
10. Popma JJ, Satler LF, Richard AD, Kent KM, Campbell A, Chuang YC, Clark C, Merritt AJ, Bucher TA, Leon MB. Vascular complications alter balloon and new device angioplasty. Circulation 1993;88:1569-1578.
11. Talley JD, Mauldin PD, Kupersmith J. Economic and angiographic factors in determining optimal catheter size in performing outpatient left-sided heart and coronary angiography. Am J Cardiol 1996;77:374-378.
12. Oldroyd KG, Phadke KV, Phillips R, Carson PH, Clarke M, Davis JA. Cardiac catheterisation by the Judkins technique as an outpatient procedure. Br Med J 1989;298:875, 876.
13. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. Am J Cardiol 1997;79:286-291.
14. Davis C, VanRiper S, Longstreet J, Moscucci M. Vascular complications of coronary interventions. Heart Lung 1997;26:118-127.
15. Moscucci M, Mansour KA, Kent KC, Kuntz RE, Senerchia C, Baim DS, Carrozza JP Jr. Peripheral vascular complications of directional coronary atherectomy and stenting: Predictors, management, and outcome. Am J Cardiol 1994;74:448-453.
16. Ferguson JJ, Califf RM, Amman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Lunger A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H,SYNERGY Trial Investigators. Enoxaparin vs unfractionatcd heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA 2004;292:45-54.
17. The SYNERGY Executive Committee. The SYNERGY trial: Study design and rationale. Am Heart J 2002;143:952-960.
18. Braunwald E, Amman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002; 40:1366-1374.
19. Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991;115:256-265.
20. The GUSTO Investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies For Acute Myocardial Infarction. N Engl J Med 1993;329:673-682.
21. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935.
22. Cohen DJ, Lincoff AM, Lavelle TA, Chen HL, Bakhai A, Berezin RH, Jackman D, Sarembock IJ, Topol EJ. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial. J Am Coll Cardiol 2004;44:1792-1800.
23. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-1562.
24. Segev A, Strauss BH, Tan M, Constance C, Langer A, Goodman SG, Canadian Acute Coronary Syndromes Registries Investigators. Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome Registries. Am Heart J 2005; 150:690-694.
25. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. Lancet 2000;356:9-16.
26. Spacek R, Widimsky P, Straka Z, Jiresova E, Dvorak J, Polasek R, Karel I, Jirmar R, Lisa L, Budesinsky T, Malek F, Stanka P. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J 2002;23:230-238.
27. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ. Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-clevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Lancet 2002;360:743-751.
28. Michalis LK, Stroumbis CS, Pappas K, Sourla E, Niokou D, Goudevenos JA, Siogas C, Sideris DA. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). Eur Heart J 2000;21:1954-1959.
29. FRagmin and Fast Revascularisation during Instability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-715.
30. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, Vassanelli C, Zardini P, Louvard Y, Hamon M. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44: 349-356.
31. Louvard Y, Ludwig J, Lefevre T, Schmeisser A, Bruck M, Scheinert D, Loubeyre C, Klinghammer L, Morice MC, Flachskampf FA, Daniel WG. Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: A dual-center registry. Catheter Cardiovasc Interv 2002;55:206-211.
32. Kassam S, Cantor WJ, Patel D, Gilchrist IC, Winegard LD, Rea ME, Bowman KA, Chisholm RJ, Strauss BH. Radial vs. femoral access for rescue percutaneous coronary intervention with adjuvant glycoprotein IIb/IIIa inhibitor use. Can J Cardiol 2004;20:1439-1442.
33. Cantor WJ, Puley G, Natarajan MK, Dzavik V, Madan M, Fry A, Kim HH, Velianou JL, Pirani N, Strauss BH, Chisholm RJ. Radial vs. femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction-The RADIAL-AMI Pilot Randomized Trial. Am Heart J 2005;150:543-549.
34. Goldberg SL, Renslo R, Sinow R, French WJ. Learning curve in the use of the radial artery as vascular access in the performance of percutaneous transluminal coronary angioplasly. Cathet Cardiovasc Diagn 1998;44:147-152.
35. Yokoyama N, Takeshita S, Ochiai M, Koyama Y, Hoshino S, Isshiki T, Sato T. Anatomic variations of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv 2000;49:357-362.
36. Gruentzig AR. Percutaneous transluminal coronary angioplasty. Semin Roentgenol 1981;16:152, 153.
37. Mehan VK, Meier B, Urban P, Verine V, Haine E, Dorsaz PA. Coronary angioplasly through 4 French diagnostic catheters. Cathet Cardiovasc Diagn 1993;30:22-26.
38. Villavicencio R, Urban P, Muller T, Favre J, Meier B. Coronary balloon angioplasty through diagnostic 6 French catheters. Cathet Cardiovasc Diagn 1991;22:56-59.
39. Metz D, Meyer P, Touati C, Coste P, Petiteau PY, Durand P, Faivre R, Lefevre T, Elaerts J. Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: Results of a prospective, multicenter, randomized trial. Am Heart J 1997;134:131-137.
40. Hui WK, Klinke WP, Kubac G, Talibi T. Comparison of 5F and 7/8F catheters for left ventricular and coronary angiography. Cathet Cardiovasc Diagn 1990;19:84-86.
41. Archbold RA, Robinson NM, Schilling RJ. Radial artery access for coronary angiography and percutaneous coronary intervention. BMJ 2004;329:443-446.
42. Simborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-1279.
43. Kussmaul WG III, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB, Kent KM, Leon MB, Kolansky DM, Sandza JG Jr. Rapid arterial emostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995; 25:1685-1692.
44. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-641.
45. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: Systematic review and meta-analysis. JAMA 2004;291:350-357.
46. Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Van de Werf F, Wallentin L. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus. Am Heart J 2002;144:615-624.